TP53 and hepatocellular carcinoma: SIRT3 deacetylates p53 in vitro like SIRT1, and it also rescues cancer cell from p53-mediated growth arrest through downregulation of Mdm2 and can potentially play an important role in the development of hepatocellular carcinoma (HCC) [114].